Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.56, read 2026-11-02
Ethical does not pass the values gate
Price77.83 USD
Fair value106.35
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-04Read Markup79.08-1.6% to today Accumulation gives way to Markup after an 11% rise in 3 weeks
2026-10-11Read Accumulation71.49+8.9% to today ✓Markdown gives way to Accumulation
2026-09-17Read Markdown69.31+12.3% to today Distribution gives way to Markdown after a 13% slide in 11 weeks
2026-07-02Read Distribution79.39-2.0% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Wyndham Hotels & Resorts, Inc. holds its Markup at $77.83. Consolidating, no directional conviction, held for 64 days.
As held on the ledger · 2026-11-05
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 64 days
Price at the screen
$77.83
Valuation
29.49 trailing · 15.05 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.64
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
61.29%
Below 33%
Interest-bearing debt is 61.3% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
8.49%
Below 49%
Money owed to the company is 8.5% of assets, under the 49% limit.
Pass
Revenue purity
0.56%
Below 5%
Only 0.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Wyndham Hotels & Resorts,'s business is in a permissible area, but its interest-bearing debt is about 61% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when WH's ethical verdict changes
Today WH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 24% discount to our $106.35 fair value, 7.30% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 26.8% discount to the base estimate.
Where our models see it going: fair-value estimate $106.35, with a range of $88.28 to $147.14, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Everyday hotel stays hide a cyclical franchisor
Picture a driver pulling into a familiar chain hotel after a long day on the road. The brand feels local yet the same logo appears across continents. Wyndham sits behind the largest franchised network in the business, with 8,300 properties and solid 38 percent ROE, yet the 4 percent revenue growth and cyclical lodging exposure keep us on the sidelines despite the 42 percent gap to our fair value.
The 14.3 times forward earnings and 13 percent profit margin look reasonable on paper and the ethical screen clears cleanly. Analyst consensus points to a $100 target, but the opportunity rating remains none because low single-digit growth in a sector tied to travel cycles rarely compounds the way a durable compounder should.
Lodging demand can swing sharply with recessions or fuel prices, so a low multiple here often signals peak earnings rather than a bargain. Currency moves and consumer spending shifts add further volatility. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
WH trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup · changed$79.08+2.2%Entry 17
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. Insiders have been net sellers over the past quarter.
2026-10-28Accumulation$77.35+0.0%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. Insiders have been net sellers over the past quarter.
2026-10-21Accumulation$77.35+6.6%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$72.59+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Accumulation$72.59+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$72.59+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Accumulation$72.59+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Accumulation$72.59-2.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Accumulation$74.06+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Accumulation$74.06+3.6%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (17 analysts) rates it buy, with a mean price target of $100. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
